Skip to main content

Corni Fructus: a review of chemical constituents and pharmacological activities


Cornus officinalis Sieb. et Zucc. is part of the genus Cornus of the family Cornaceae. Ripening and dry fruits (Corni Fructus) are recognized as an essential herb medicine in the traditional Chinese medicine (TCM) and have been widely used for over 2000 years. This review provides a comprehensive summary of Corni Fructus (CF), including the botany, phytochemistry, traditional use, and current pharmacological activities. According to the basic theory of TCM, CF usually participates in various Chinese medicinal formulae to exert the essential roles in replenishing liver and kidney, arresting seminal emission and sweat. Based on modern pharmacological studies, about 90 compounds have been isolated and identified from CF. In vivo and in vitro experimental studies indicate that CF exhibits extensive pharmacological activities including hypoglycemic, antioxidant, anti-inflammatory, anticancer, neuroprotective, hepatoprotective, and nephroprotective activities. However, only about 18% of chemical constituents in CF were tested. It means the potential pharmacological activities and clinical values of CF need to be further investigated.


Cornus officinalis Sieb. et Zucc., commonly known as Shan Zhu Yu/山茱萸 (in Chinese), Asiatic Dogwood, and Japanese Cornel Dogwood, is a deciduous shrub or dungarunga in the genus Cornus (family Cornaceae). It is a heliophilous plant that grows in the warm-temperate zone. The most suitable growth temperature is between 20 and 30 °C, it also has a specific cold resistance that can temporarily grow in − 18 °C low-temperature zone. Cornus officinalis Sieb. et Zucc. can be found in Anhui, Gansu, Jiangsu, Jiangxi, Shandong, Shanxi in China, Korea, and Japan. It usually grows in 400–1500 m high mountain slope, forest or forest edge. Ripening fruits are picked during September and October and dried in the air for medical uses [1, 2].

About 2200 years ago, Cornus officinalis Sieb. et Zucc. fructus (usually known as Corni Fructus) was first recorded in Shen Nong’s Materia Medica (Fig. 1). According to the basic theory of TCM, CF is characterized as replenishing liver and kidney, arresting seminal emission and sweat for its sour, astringent, and tepid properties [1]. It is used to treat four series of clinical symptoms. The first part of symptoms contains vertigo, tinnitus, weakness of the waist and knees which are caused by liver and kidney deficiency. CF is usually combined with Radix Rehmanniae Praeparata, Dioscoreae Rhizoma, Alismatis Rhizoma, Moutan Cortex, Poria to make Liuwei Dihuang Wan (六味地黄丸) replenish liver and kidney Yin [3]. For patients with kidney Yang deficiency, CF helps Cinnamomi Cortex, Aconiti Lateralis Radix Praeparata to reinforce Yang from Yin, e.g., Jingui Shenqi Wan (金匮肾气丸) [4]. The second part of symptoms contains spermatorrhoea and polydipsia. For patients with kidney deficiency, CF is frequently used with Radix Rehmanniae Praeparata, Dioscoreae Rhizoma, Cervi Cornu Pantotrichum, Psoraleae Fructus. For patients with dysfunction of the urinary bladder, CF is often applied with Mantidis Oötheca, Rubi Fructus, Rosae Laevigatae Fructus. The third part of symptom contains hypermenorrhea. CF is usually combined with Radix Rehmanniae Praeparata, Angelica Sinensis, Radix Paeoniae Alba to make Guchong Tang (固冲汤) preserve Primordial Qi and stop Blood [5]. The fourth part of symptoms contains profuse cold sweating, pale complexion, cold limbs, and a feeble pulse. For patients with the Yang depletion syndrome, Ginseng Radix et Rhizoma, Aconiti Lateralis Radix Praeparata, and CF are applied in Laifu Tang (来复汤) to restore Yang from collapse. Medical practices indicate that CF can be combined with either Yin-tonifying or Yang-invigorating herbs to act as the sovereign drug or adjuvant drug in Chinese medicinal formulae and treat different types of TCM syndromes. Besides, CF is primarily made into the honey bolus to treat chronic diseases while is usually made into the decoction to treat acute conditions.

Fig. 1

Corni Fructus: a crude fruits, b processed fruits

Chemical constituents

About 90 compounds have been isolated and identified from CF, including terpenoids, flavonoids, tannins, polysaccharides, phenylpropanoids, sterols, carboxylic acids, furans, and mineral substances. Chemical constituents are listed in Table 1. Among them, iridoids, tannins, and flavonoids are the major components. Their chemical structures are shown in Figs. 2, 3, 4 and 5.

Table 1 Chemical constituents identified from CF
Fig. 2

Structures of chemical constituents from Corni Fructus

Fig. 3

Structures of chemical constituents from Corni Fructus

Fig. 4

Structures of chemical constituents from Corni Fructus

Fig. 5

Structures of chemical constituents from Corni Fructus

Terpenoids (126) and flavonoids (2739)

Most terpenoids and flavonoids in CF shared two similar isolation processes. Firstly, CF was percolated with ethanol to acquire the solvent which was then evaporated under reduced pressure. The resulting extract was suspended in water and then partitioned with ethyl acetate for several times. Finally, the extract was subjected to column chromatography over silica gel to yield compounds. Secondly, CF was grounded into powder and then subjected to supercritical carbon dioxide to yield extract. The resulting extract was subjected to GC–MS to identify the chemical components. So far, 26 terpenoids and 13 flavonoids have been isolated and identified from CF. Among terpenoids, the pharmacological activities of sweroside (1), loganin (5), cornuside (23), ursolic acid (24), and oleanolic acid (25) have been further assayed, and a wide range of pharmacological activities has been revealed. Furthermore, two types of flavonoids namely kaempferol (28), quercetin (33), and their derivatives are the essential flavonoids.

Tannins (4069)

During the isolation process, CF was firstly homogenized in acetone and then filtered to acquire an aqueous solution which was sequentially extracted with diethyl ether and ethyl acetate. The extract was subjected to column chromatography to give compounds. Finally, the chemical structure and molecular weight were determined using nuclear magnetic resonance (NMR) spectroscopy. To date, 30 tannic acids have been isolated from CF. Tsutomu HATANO identified 28 of them. Many tannic acids in this Chinese herb have the large molecular weight, e.g., the molecular weight of Cornusiins A–F and Camptothins A–B are even larger than 1000 Da [6, 7], because dimers and trimers exist in these types of tannic acids.

Polysaccharides (7079)

Wu and Yin identified most polysaccharides in CF [8, 9]. In their isolation process, hot water or petroleum ether was initially used for combining with assistant ultrasonic and microwave to break the cell wall to isolate polysaccharides. Further separation and purification were achieved by the combination of several techniques, e.g., fractional precipitation, ethanol precipitation, ion-exchange chromatography and affinity chromatography. Finally, infrared spectroscopy analysis and morphological analysis were used to determine the physiochemical and structural features of the polysaccharide.

Other compounds (8093)

Four phenylpropanoids, two sterols, five carboxylic acids, two furans, and several mineral substances have also been determined. Among them, 5-hydroxymethylfurfural exhibits diverse biological activities. Besides, Chen, Li, and Wen identified 32, 16, and 48 volatile compounds by GC–MS, respectively [10,11,12].

Pharmacological activities

Although just a few chemical constituents from CF are assayed for their biological activities, these components displayed diverse pharmacological activities. Detailed biological activities are summarized in Table 2.

Table 2 Summary of pharmacological activities of CF

Hypoglycemic activity and diabetic target organs protective activity

Diabetes mellitus (DM) is a group of long-term and chronic metabolic disorders which are associated with high serum glucose levels. Compared with the no treatment diabetic animal model group, CF extract (at 300 mg kg−1 2 day−1 and 400 mg kg−1 day−1 p.o.), loganin, morroniside, and ursolic acid (each at 200 mg kg−1 day−1 p.o.) for 4 weeks can significantly decrease fasting blood glucose and alleviate polyphagia, polydipsia, polyuria, and weight loss [13, 14]. In He’s study, metformin (at 200 mg kg−1 day−1 p.o.) demonstrated better effect [14]. Besides, loganin, morroniside, ursolic acid, and butyl morroniside (each at 100 μmol L−1) can protect the pancreatic β-cells from high glucose-induced excessive oxidative stress and apoptosis [14, 15], may further increase the insulin release. Compared with the insulin treatment, CF extract, (−)-epicatechin-3-O-gallate, and caftaric acid monomethyl ester (each at 50 μmol L−1) can also significantly inhibit α-glucosidase activity to slow down the elevation of serum glucose levels [14, 16, 17] and suppress the hepatic gluconeogenesis by decreasing the protein and mRNA levels of PEPCK in vitro [15, 18].

Also, CF extract, iridoid glycosides, and the single compound can decrease 24 h urine protein and serum levels of urea nitrogen and creatinine. To be specific, loganin, morroniside, and 7-O-galloyl-d-sedoheptulose (each at 20–100 mg kg−1 day−1 p.o.) for 10 days and 8 weeks can significantly inhibit both AGE/RAGE formation [19,20,21,22] and CTGF production [23] in db/db mice or STZ-induced diabetic nephropathy model. They can also significantly alleviate diabetic organ injury by decreasing the production of NF-κB and its downstream synthetases and cytokines [19,20,21,22,23,24,25], increasing antioxidant enzyme production [19, 26, 27], and suppressing apoptotic cell death [27, 28].

Antioxidant activity

Long-term oxidative stress will generate excessive ROS to oxidize protein, lipids, DNA and then cause cell death, tissue damage, and organ dysfunction. Ideal antioxidant drugs are required to regulate the defense system and scavenge excessive ROS. Studies indicated that morroniside (at 1, 10, 100 μmol L−1) for 24 h and total saponins (at 60 and 120 mg kg−1 day−1 p.o.) for 4 weeks regulated Ca2+ and NO release [29, 30], the aqueous extract (at 0.25–2.0 mg mL−1) for 20 h modulated GSH redox cycle [31], the aqueous extract, the ethanol extract (at 0.01–0.1 mg mL−1), morroniside (at 0.05–2 µg mL−1), and ursolic acid (at 0.05–2 µg mL−1) for 24 h promoted antioxidant enzymes syntheses [31,32,33] to inhibit lipid peroxidation [29], 5-hydroxymethylfurfural (at 100–400 μmol L−1) for 3 days decreased ROS release [34], morroniside (at 100 μmol L−1) for 2 days recovered cell cycle to normal state [35]. Mentioned effects significantly together reduced the oxidative stress-induced damages compared with the no treatment group.

Anti-inflammatory activity

Prolonged and incurable inflammation may cause many diseases, e.g., atherosclerosis, cancer, ulcerative colitis. In LPS and TNF-α-induced cell inflammation models, compared with the no treatment group, CF aqueous extract (at 0.2, 1, 5 mg mL−1) and cornuside (at 1, 10, 50 μmol L−1) for 24 h significantly inhibited NF-κB p65 translocation, down-regulated COX-2 and iNOS production, finally decreased PGE2 and NO levels to control excessive inflammatory responses [36,37,38].

Anticancer activity

CF aqueous extract significantly enhanced both the cytotoxicity and superoxide anion scavenging activity of vitamin C at 0.5 and 36 µg mL−1, respectively. Together with CF aqueous extract, vitamin C further inhibited proliferation and induced apoptosis in several human oral squamous cell carcinoma cell lines. Compared with no treatment, the proliferation inhibition rate was at 1.3–71.0% [39]. Furthermore, the aqueous extract (at 1.0 mg mL−1) for 2 days significantly exhibited anti-ER+ human mammary carcinoma activity by inhibiting cell anchorage-independent growth, regulating the metabolism of E2 and E3 [40], and influencing cell cycle progression and cellular apoptosis [41]. Finally, the aqueous extract has been tested for its cancer inhibitory effect in several hepatocellular carcinomas and leukemic cell lines. The study indicated that the aqueous extract inhibited the tumor cell proliferation in a dose-dependent manner at 0.11–0.337 mg mL−1, exhibited oxygen free radicals scavenging activity (at 50 µg mL−1), attenuated xanthine oxidase production (at 2.62 mg mL−1) and lipid peroxidation (at 0.892 mg mL−1) [42]. In this study, CF aqueous extract exhibited the similar effects compared with 5-fluorouracil (at 0.5, 1, 5 µg mL−1).

Neuroprotective activity

Many compounds in CF were further tested for the neuroprotective effects. 7R-O-Methyl-morroniside, 7S-O-methyl-morroniside, 7-O-butyl-morroniside, loganin, and morroniside (each at 10 and 50 μmol L−1) for 1 h significantly protected the neurons against glutamate-induced neurotoxicity up to about 78% compared with the no treatment group [43]. CF aqueous extract (at 60 µg mL−1) significantly inhibited the extracellular Ca2+ influx to increase cell neurite outgrowth [44]. Also, cornuside, isoterchebin, and tellimagrandin II (each at 25–100 μmol L−1) displayed anti-Alzheimer’s disease potential due to their synergetic inhibitory activities against BACE1 and ChE [45].

Cerebral ischemia, multiple sclerosis, and neurodegenerative disorder models are applied in animal experiments. Iridoid glycosides (at 60 and 180 mg kg−1 day−1 p.o.) for 1–4 weeks and morroniside (at 90 and 270 mg kg−1 day−1 p.o.) for 3 days significantly decreased the infarction volume, increased the number of new mature neurons and blood vessels, and improved nervous system function [46, 47]. Also, iridoid glycosides (at 50–180 mg kg−1 day−1 p.o.) for 3–4 weeks can significantly promote NGF and BDNF production [48,49,50], and repair the abnormal functions of microglia, oligodendrocyte, and T cell to maintain the central nervous system homeostasis [48].

Hepatoprotective activity

In hepatitis cell models, 5-hydroxymethylfurfural (at 0.2–1 and 0.79 μmol L−1) for 24 h has been shown to protect hepatocytes from H2O2 induced-cytotoxicity by significantly decreasing NO and intracellular Ca2+ levels, inhibiting abnormal production of apoptosis-related proteins and recovering back to regular cell cycle [51,52,53]. In hepatitis animal models, 7-O-galloyl-d-sedoheptulose (at 20 and 100 mg kg−1 day−1 p.o.) for 6 weeks and CF ethanol extract (at 100–500 mg kg−1 day−1 p.o.) for 1 week significantly decreased the serum marker enzymes of hepatic damage, weakened the oxidative stress by promoting antioxidant enzymes production and inhibiting lipid peroxidation, finally improved hepatic histological injury [54, 55].

Other pharmacological activities

In addition to the mentioned pharmacological activities, CF has also been reported to exert multiple bioactivities. Firstly, sweroside (at 7.5 µg mL−1) for 1 week significantly promoted the proliferation and differentiation of osteoblasts via the regulation of osteocalcin [56]. Also, CF extract (at 0–100 µg mL−1) for 4 days significantly inhibited osteoclast differentiation in a dose-dependent manner via the inhibition of the signaling cascades NF-κB/c-Fos/NFATc1 to improve osteoporosis [57]. Secondly, CF methanol extract (at 3.125–12.5 µg mL−1) for 3 days significantly up-regulated synthesis and activity of tyrosinase, raised TRP-1&2 translation associating with increasing transcription of MITF-M, finally promoted melanogenesis by 36.1% [58]. Thirdly, CF aqueous extract possesses immunomodulatory activity. In C57BL/6 mice that were transplanted with a skin graft from Balb/C donors, CF extract significantly prolonged skin allograft survival synergistically by suppressing Th1 response, promoting regulatory T cell generation, and enhancing its suppressive function [59]. Fourthly, CF shows lung-protective activity via two studies. In the cellular test, oleanolic acid (at 10 and 100 μmol L−1) and ursolic acid (at 100 μmol L−1) for 30 min’ pretreatment significantly down-regulated MUC5AC mucin whose excessive level would impair airway defenses to cause serious airway diseases [60]. In an animal experiment, CF aqueous extract (at 50 and 200 mg kg−1 3 day−1 p.o.) for 5 weeks significantly decreased the production of inflammatory mediators and reduced eosinophil infiltration, finally attenuated allergic airway inflammation and airway hyperresponsiveness [61]. Fifthly, cornuside significantly dilated vascular smooth muscle in phenylephrine-contracted rat aorta via the up-regulation of cGMP level to show its vasorelaxation activity [62]. Finally, among in vitro screening of antiviral drugs for treating hand, foot, and mouth disease (HFMD) infection, CF aqueous extract (at 0.4 µg mL−1) for 2 days significantly inhibited CVA16 replication in cellular level [63].


CF is recognized as a fundamental constituent part of tonifying Yin and Yang prescription because of its harmonious and complementary features according to the basic theory of TCM. It possesses the properties of sour and astringent. Firstly, sour and sweet herbs can be combined to nourish Yin, it can act as the sovereign and ministerial drug among Radix Rehmanniae Praeparata, Dioscoreae Rhizoma, Lycii Fructus, Ligustri Lucidi Fructus, Schisandrae Chinensis Fructus. Also, sour and astringent properties exhibit their function of astringing and storing. It also behaves as the sovereign and the ministerial drug that combines with Euryales Semen, Sepiae Endoconcha, Mantidis Oötheca, Rubi Fructus, Paeoniae Radix Alba to treat spermatorrhea, urorrhagia, metrorrhagia and metrostaxis, and excessive perspiration. Finally, CF can be as the adjuvant and conductant drug to alleviate warm and dry features of Yang-reinforcing drugs.

Chemical constituents from terpenoids, flavonoids, tannins, and furans exhibited diverse biological activities, including hypoglycemic, neuroprotective, heart-protective, hepatoprotective, nephroprotective, testis-protective activities. Pharmacological activities are outlined in Fig. 6. In these studies, bioactive components from CF mainly alleviated the damage of target organs by antioxidant activity, anti-inflammatory activity, and anti-apoptosis activity, i.e., up-regulating the expressions and activities of antioxidant enzymes, down-regulating the levels of cytokines and chemokines, and modulating the abnormal expressions of apoptotic death associated proteins.

Fig. 6

The various pharmacological activities of the extract and chemical compounds identified from Corni Fructus

Hypoglycemic activity and alleviating diabetic target organs damage are critical pharmacological activities among the broad spectrum of pharmacological activities of CF. Morroniside, loganin, oleanolic acid, ursolic acid, and 7-O-galloyl-d-sedoheptulose exhibited the similar efficacy compared with the conventional oral hypoglycemic drugs (acarbose and metformin). In vivo studies, they reduced serum glucose levels and alleviated unusual symptoms caused by diabetes. In cellular assays, they protected pancreatic β cell from oxidative damage, increased insulin release, improved insulin resistance, displayed α-glucosidase inhibition activity, and suppressed liver gluconeogenesis. Also, compounds alleviated the high-glucose triggered target organs damage by attenuating oxidative stress, inflammation, and apoptosis, finally kept the essential function of target organs stable. CF has also been widely used to treat DM in clinical work. For example, Jingui Shenqi Wan and Liuwei Dihuang Wan are two classic Chinese medicinal formulae which contain CF. Clinical trials indicated that Jingui Shenqi Wan and Liuwei Dihuang Wan could decrease serum glucose levels, alleviate typical DM symptoms and repair target organs injury [64,65,66,67]. Diverse anti-diabetes and anti-diabetic complication pharmacological activities make CF a potential herb to become the complementary drug for treating DM.

Another significant biological activity is the neuroprotection. In cerebral ischemia rat model and neurodegenerative disorder cellular model, iridoid glycosides (e.g., morroniside) and 5-hydroxymethylfurfural increased the number of new mature neurons and blood vessels and exerted anti-oxidative stress, anti-inflammation, and anti-apoptosis properties. In cerebral ischemia rat model and multiple sclerosis rats and mice models, iridoid glycosides also enhanced the levels of brain-derived neurotrophic factor and nerve growth factor. Current studies showed that the pathogenic mechanisms of neurodegenerative diseases have the close relationship with autophagy deficiency and abnormal proteins aggregate clearance dysfunction [68, 69]. In addition to the anti-apoptotic activity, pharmacological activities of CF on the regulation of autophagy can be further explored. Furthermore, many classic Chinese medicinal formulae have been used to treat neurological disorders belonging to liver and kidney deficiency [70,71,72]. For example, Liuwei Dihuang Wan treats insomnia, Zuogui Wan (左归丸) treats epilepsy and vertigo, Dabu Yinjian (大补阴煎) treats a headache, Zuogui Wan and Dihuang Yinzi (地黄饮子) treats stroke, and Huanshao Dan (还少丹) treats dementia. CF plays a vital role in nourishing liver and kidney Yin in these Chinese medicinal formulae.

However, about 90 compounds have been isolated and identified from CF, only 18% compounds are further assayed for their pharmacological activities in vivo and in vitro. It indicates that pharmacological activities of the remaining 90% chemical components are still unknown yet. Moreover, current studies do not provide enough evidence to verify the drug binding sites of active ingredients of CF. For example, it is difficult to judge whether these active ingredients bind the G protein coupled receptor, ion channels, transmembrane receptor kinases, or nuclear receptors to work. Therefore, more systematic and detailed pharmacological studies on CF need to be fulfilled in the future.



acetyl choline


advances glycation endproducts


alkaline phosphatase


alanine aminotransferase


aspartate aminotransferase


activating transcription factor 4


b-site amyloid precursor protein cleaving enzyme 1


bcl-2-associated X


B-cell lymphoma-2


brain-derived neurotrophic factor


bone marrow-derived macrophages










C/EBP homologous protein





Col V:

collagen V




connective tissue growth factor


Coxsackie virus A group 16 strain

Cyt c:

cytochrome C


dendritic cells






endothelin converting enzyme


extracellular matrix

ER+ :

estrogen receptor-positive


extracellular-signal-related kinase 1/2






growth-associated protein-43


gas chromatography–mass spectrometry


glutathione peroxidase




glycated serum protein


glutathione disulfide


human renal proximal tubular epithelial cells


heme oxygenase-1


human umbilical vein endothelial cells


intercellular adhesion molecule-1


inducible nitric oxide synthase






c-Jun N-terminal kinase




mitogen-activated protein kinase


middle cerebral artery occlusion


monocyte chemoattractant protein 1




microphthalmia-associated transcription factor-M


mitochondrial membrane potential


nuclear factor-kappa B


nuclear factor of activated T cells cytoplasmic 1


nerve growth factor


nitric oxide


osteoclast-associated receptor




p-eukaryotic initiation factor 2 alpha


pulmonary artery endothelial cells


phosphoenolpyruvate carboxykinase


protein kinase R (PKR)-like endoplasmic reticulum kinase

PGE2 :

prostaglandin E2




per os


receptor of AGE


receptor activator of nuclear factor kappa-Β ligand


reactive oxygen species


sarcoplasmic reticulum Ca2+-ATPase 2a


superoxide dismutase


sphingosine kinase 1


sterol regulatory element binding protein-1&2


sensor protein stromal interaction molecule 1






thiobarbituric acid-reactive substance




total cholesterol


transforming growth factor


tumor necrosis factor-α


tartrate-resistant acid phosphatase

Trk A:

tyrosine receptor kinase A


tyrosinase-related protein-1&2


vascular cell adhesion molecule-1


vascular endothelial growth factor


  1. 1.

    Chinese Pharmacopoeia Commission. People’s Republic of China pharmacopoeia 2015 edition, 1st part. Beijing: China Medical Science Press; 2015. p. 27–8 (in Chinese).

    Google Scholar 

  2. 2.

    Xiang CK. Research progress on resources and active components of Cornus officinalis. Hebei Med J. 2016;38:1886–9 (in Chinese).

    CAS  Google Scholar 

  3. 3.

    Song XY, Chen Q, Qi XY. Effect of Liuwei Dihuang pill on erythrocyte aldose reductase activity in early diabetic nephropathy patients. Chin J Integr Tradit West Med. 2004;24:1087–90.

    Google Scholar 

  4. 4.

    Liu XD, Fu J, Feng MZ, Zhang ZH. Effect of Jinggui Shenqi pill combined with nifedipine for the treatment of elderly hypertensive patients with spleen–kidney Yang deficiency syndrome. China J Chin Mater Med. 2015;40:4908–12 (in Chinese).

    Google Scholar 

  5. 5.

    Wang Y, Wang C. Three cases of clinical application of Guchong Decoction. China J Tradit Chin Med Pharm. 2010;25:2041–3 (in Chinese).

    Google Scholar 

  6. 6.

    Hatano T, Ogawa N, Kira R, Yasuhara T, Okuda T. Tannins of cornaceous plants. I. Cornusiins A, B and C, dimeric monomeric and trimeric hydrolyzable tannins from Cornus officinalis, and orientation of valoneoyl group in related tannins. Chem Pharm Bull. 1989;37:2083–90.

    Article  PubMed  CAS  Google Scholar 

  7. 7.

    Hatano T, Ogawa N, Kira R, Yasuhara T, Okuda T. Tannins of cornaceous plants. II. Cornusiins D, E and F, new dimeric and trimeric hydrolyzable Tannins from Cornus officinalis. Chem Pharm Bull. 1989;37:2665–9.

    Article  CAS  Google Scholar 

  8. 8.

    Wu Y, Wang X, Shen B, Kang L, Fan E. Extraction, structure, and bioactivities of the polysaccharides from Fructus corni. Recent Pat Food Nutr Agric. 2013;5:57–61.

    Article  PubMed  CAS  Google Scholar 

  9. 9.

    Yin X, You Q, Jiang Z, Zhou X. Optimization for ultrasonic-microwave synergistic extraction of polysaccharides from Cornus officinalis and characterization of polysaccharides. Int J Biol Macromol. 2016;83:226–32.

    Article  PubMed  CAS  Google Scholar 

  10. 10.

    Chen H, Zhang HJ, Zhang MJ, Xiao ZH. Orthogonal test for optimization of extraction condition for volatile components of Cornus officinalis and extract analysis by GC–MS. J Third Mil Med Univ. 2007;29:1079–82 (in Chinese).

    CAS  Google Scholar 

  11. 11.

    Li GY, Yao YX, Ding X. Studies on chemistry component and the biological activity of petroleum ether extraction from pre- and post-processed of Cornus officinalis. Zhong Yao Cai. 2010;33:192–5 (in Chinese).

    PubMed  CAS  Google Scholar 

  12. 12.

    Wen YY, Ren Q, Zhang GM, Li AN, Ding ZE. Analysis of the essential oils from Cornus officinalis by simultaneous distillation extraction coupled with gas chromatography–mass spectrometry. Food Ferment Ind. 2010;36:166–70.

    Google Scholar 

  13. 13.

    Han Y, Jung HW, Park YK. Selective therapeutic effect of Cornus officinalis fruits on the damage of different organs in STZ-induced diabetic rats. Am J Chin Med. 2014;42:1169–82.

    Article  PubMed  Google Scholar 

  14. 14.

    He K, Song S, Zou Z, Feng M, Wang D, Wang Y, Li X, Ye X. The hypoglycemic and synergistic effect of loganin, morroniside, and ursolic acid isolated from the fruits of Cornus officinalis. Phytother Res. 2015;30:283–91.

    Article  PubMed  CAS  Google Scholar 

  15. 15.

    Lin MH, Liu HK, Huang WJ, Huang CC, Wu TH, Hsu FL. Evaluation of the potential hypoglycemic and beta-cell protective constituents isolated from Corni Fructus to tackle insulin-dependent diabetes mellitus. J Agric Food Chem. 2011;59:7743–51.

    Article  PubMed  CAS  Google Scholar 

  16. 16.

    He LH. Comparative study on alpha-glucosidase inhibitory effects of total iridoid glycosides in the crude products and the wine-processed products from Cornus officinalis. Yakugaku Zasshi. 2011;131:1801–5.

    Article  PubMed  CAS  Google Scholar 

  17. 17.

    Park CH, Noh JS, Tanaka T, Uebaba K, Cho EJ, Yokozawa T. The effects of Corni Fructus extract and its fractions against α-glucosidase inhibitory activities in vitro and sucrose tolerance in normal rats. Am J Chin Med. 2011;39:367–80.

    Article  PubMed  Google Scholar 

  18. 18.

    Chen CC, Hsu CY, Chen CY, Liu HK. Fructus Corni suppresses hepatic gluconeogenesis related gene transcription, enhances glucose responsiveness of pancreatic beta-cells, and prevents toxin induced beta-cell death. J Ethnopharmacol. 2008;117:483–90.

    Article  PubMed  Google Scholar 

  19. 19.

    Yokozawa T, Kang KS, Park CH, Noh JS, Yamabe N, Shibahara N, Tanaka T. Bioactive constituents of Corni Fructus: the therapeutic use of morroniside, loganin, and 7-O-galloyl-d-sedoheptulose as renoprotective agents in type 2 diabetes. Drug Discov Ther. 2010;4:223–34.

    PubMed  CAS  Google Scholar 

  20. 20.

    Yamabe N, Kang KS, Goto E, Tanaka T, Yokozawa T. Beneficial effect of Corni Fructus, a constituent of Hachimi-jio-gan, on advanced glycation end-product-mediated renal injury in streptozotocin-treated diabetic rats. Biol Pharm Bull. 2007;30:520–6.

    Article  PubMed  CAS  Google Scholar 

  21. 21.

    Yamabe N, Kang KS, Park CH, Tanaka T, Yokozawa T. 7-O-galloyl-d-sedoheptulose is a novel therapeutic agent against oxidative stress and advanced glycation endproducts in the diabetic kidney. Biol Pharm Bull. 2009;32:657–64.

    Article  PubMed  CAS  Google Scholar 

  22. 22.

    Lv X, Dai G, Lv G, Chen Y, Wu Y, Shen H, Xu H. Synergistic interaction of effective parts in Rehmanniae Radix and Cornus officinalis ameliorates renal injury in C57BL/KsJ-db/db diabetic mice: involvement of suppression of AGEs/RAGE/SphK1 signaling pathway. J Ethnopharmacol. 2016;185:110–9.

    Article  PubMed  Google Scholar 

  23. 23.

    Jiang WL, Zhang SP, Hou J, Zhu HB. Effect of loganin on experimental diabetic nephropathy. Phytomedicine. 2012;19:217–22.

    Article  PubMed  CAS  Google Scholar 

  24. 24.

    Ma W, Wang KJ, Cheng CS, Yan GQ, Lu WL, Ge JF, Cheng YX, Li N. Bioactive compounds from Cornus officinalis fruits and their effects on diabetic nephropathy. J Ethnopharmacol. 2014;153:840–5.

    Article  PubMed  CAS  Google Scholar 

  25. 25.

    Xu HQ, Hao HP. Effects of iridoid total glycoside from Cornus officinalis on prevention of glomerular overexpression of transforming growth factor beta 1 and matrixes in an experimental diabetes model. Biol Pharm Bull. 2004;27:1014–8.

    Article  PubMed  CAS  Google Scholar 

  26. 26.

    Qi MY, Liu HR, Dai DZ, Li N, Dai Y. Total triterpene acids, active ingredients from Fructus Corni, attenuate diabetic cardiomyopathy by normalizing ET pathway and expression of FKBP12.6 and SERCA2a in streptozotocin-rats. J Pharm Pharmacol. 2008;60:1687–94.

    Article  PubMed  CAS  Google Scholar 

  27. 27.

    Chen Y, Wu Y, Gan X, Liu K, Lv X, Shen H, Dai G, Xu H. Iridoid glycoside from Cornus officinalis ameliorated diabetes mellitus-induced testicular damage in male rats: involvement of suppression of the AGEs/RAGE/p38 MAPK signaling pathway. J Ethnopharmacol. 2016;194:850–60.

    Article  PubMed  CAS  Google Scholar 

  28. 28.

    Pi WX, Feng XP, Ye LH, Cai BC. Combination of morroniside and diosgenin prevents high glucose-induced cardiomyocytes apoptosis. Molecules. 2017;22:163.

    Article  CAS  Google Scholar 

  29. 29.

    Wang W, Sun F, An Y, Ai H, Zhang L, Huang W, Li L. Morroniside protects human neuroblastoma SH-SY5Y cells against hydrogen peroxide-induced cytotoxicity. Eur J Pharmacol. 2009;613:19–23.

    Article  PubMed  CAS  Google Scholar 

  30. 30.

    Liu Y, Liu H, Zhang J. Total saponins of Cornus officinalis Sieb. ameliorates the endothelium dependent relaxation of mesenteric artery by regulating nitric oxide release in streptozotocin-induced diabetic rats. Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2012;37:757–64.

    Article  PubMed  CAS  Google Scholar 

  31. 31.

    Peng Q, Wei Z, Lau BH. Fructus corni enhances endothelial cell antioxidant defenses. Gen Pharmacol. 1998;31:221–5.

    Article  PubMed  CAS  Google Scholar 

  32. 32.

    Yu HH, Hur JM, Seo SJ, Moon HD, Kim HJ, Park RK, You YO. Protective effect of ursolic acid from Cornus officinalis on the hydrogen peroxide-induced damage of HEI-OC1 auditory cells. Am J Chin Med. 2009;37:735–46.

    Article  PubMed  CAS  Google Scholar 

  33. 33.

    Hwang KA, Hwang YJ, Song J. Antioxidant activities and oxidative stress inhibitory effects of ethanol extracts from Cornus officinalis on raw 264.7 cells. BMC Complement Altern Med. 2016;16:196.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  34. 34.

    Cao G, Cai H, Cai B, Tu S. Effect of 5-hydroxymethylfurfural derived from processed Cornus officinalis on the prevention of high glucose-induced oxidative stress in human umbilical vein endothelial cells and its mechanism. Food Chem. 2013;140:273–9.

    Article  PubMed  CAS  Google Scholar 

  35. 35.

    Xu HQ, Hao HP, Zhang X, Pan Y. Morroniside protects cultured human umbilical vein endothelial cells from damage by high ambient glucose. Acta Pharmacol Sin. 2004;25:412–5.

    PubMed  CAS  Google Scholar 

  36. 36.

    Kang DG, Moon MK, Lee AS, Kwon TO, Kim JS, Lee HS. Cornuside suppresses cytokine-induced proinflammatory and adhesion molecules in the human umbilical vein endothelial cells. Biol Pharm Bull. 2007;30:1796–9.

    Article  PubMed  CAS  Google Scholar 

  37. 37.

    Chu Q, Hashimoto K, Satoh K, Wang Q, Sakagami H. Effect of three herbal extracts on NO and PGE2 production by activated mouse macrophage-like cells. In Vivo. 2009;544:537–44.

    Google Scholar 

  38. 38.

    Choi YH, Jin GY, Li GZ, Yan GH. Cornuside suppresses lipopolysaccharide-induced inflammatory mediators by inhibiting nuclear factor-kappa B activation in RAW 264.7 macrophages. Biol Pharm Bull. 2011;34:959–66.

    Article  PubMed  CAS  Google Scholar 

  39. 39.

    Chu Q, Satoh K, Kanamoto T, Terakubo S, Nakashima H, Wang Q, Sakagami H. Antitumor potential of three herbal extracts against human oral squamous cell lines. Anticancer Res. 2009;29:3211–9.

    PubMed  Google Scholar 

  40. 40.

    Telang NT, Li G, Sepkovic DW, Bradlow HL, Wong GY. Anti-proliferative effects of Chinese herb Cornus officinalis in a cell culture model for estrogen receptor-positive clinical breast cancer. Mol Med Rep. 2012;5:22–8.

    PubMed  CAS  Google Scholar 

  41. 41.

    Telang N, Li G, Katdare M, Sepkovic D, Bradlow L, Wong G. Inhibitory effects of Chinese nutritional herbs in isogenic breast carcinoma cells with modulated estrogen receptor function. Oncol Lett. 2016;12:3949–57.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  42. 42.

    Chang JS, Chiang LC, Hsu FF, Lin CC. Chemoprevention against hepatocellular carcinoma of Cornus officinalis in vitro. Am J Chin Med. 2004;32:717–25.

    Article  PubMed  Google Scholar 

  43. 43.

    Jeong EJ, Kim TB, Yang H, Kang SY, Kim SY, Sung SH, Kim YC. Neuroprotective iridoid glycosides from Cornus officinalis fruits against glutamate-induced toxicity in HT22 hippocampal cells. Phytomedicine. 2012;19:317–21.

    Article  PubMed  CAS  Google Scholar 

  44. 44.

    Wang X, Liu J, Jin N, Xu D, Wang J, Han Y, Yin N. Fructus corni extract-induced neuritogenesis in PC12 cells is associated with the suppression of stromal interaction molecule 1 expression and inhibition of Ca2+ influx. Exp Ther Med. 2015;9:1773–9.

    Article  PubMed  PubMed Central  Google Scholar 

  45. 45.

    Bhakta HK, Park CH, Yokozawa T, Tanaka T, Jung HA, Choi JS. Potential anti-cholinesterase and β-site amyloid precursor protein cleaving enzyme 1 inhibitory activities of cornuside and gallotannins from Cornus officinalis fruits. Arch Pharm Res. 2017;40:836–53.

    Article  PubMed  CAS  Google Scholar 

  46. 46.

    Yao RQ, Zhang L, Wang W, Li L. Cornel iridoid glycoside promotes neurogenesis and angiogenesis and improves neurological function after focal cerebral ischemia in rats. Brain Res Bull. 2009;79:69–76.

    Article  PubMed  CAS  Google Scholar 

  47. 47.

    Wang W, Xu J, Li L, Wang P, Ji X, Ai H, Zhang L, Li L. Neuroprotective effect of morroniside on focal cerebral ischemia in rats. Brain Res Bull. 2010;83:196–201.

    Article  PubMed  CAS  Google Scholar 

  48. 48.

    Yin L, Chen Y, Qu Z, Zhang L, Wang Q, Zhang Q, Li L. Involvement of JAK/STAT signaling in the effect of cornel iridoid glycoside on experimental autoimmune encephalomyelitis amelioration in rats. J Neuroimmunol. 2014;274:28–37.

    Article  PubMed  CAS  Google Scholar 

  49. 49.

    Zhao L, Ding Y, Zhang L, Li L. Cornel iridoid glycoside improves memory ability and promotes neuronal survival in fimbria–fornix transected rats. Eur J Pharmacol. 2010;647:68–74.

    Article  PubMed  CAS  Google Scholar 

  50. 50.

    Qu Z, Zheng N, Zhang Y, Zhang L, Liu J, Wang Q, Yin L. Preventing the BDNF and NGF loss involved in the effects of cornel iridoid glycoside on attenuation of experimental autoimmune encephalomyelitis in mice. Neurol Res. 2016;38:831–7.

    Article  PubMed  CAS  Google Scholar 

  51. 51.

    Ding X, Wang MY, Yao YX, Li GY, Cai BC. Protective effect of 5-hydroxymethylfurfural derived from processed Fructus Corni on human hepatocyte L02 injured by hydrogen peroxide and its mechanism. J Ethnopharmacol. 2010;128:373–6.

    Article  PubMed  CAS  Google Scholar 

  52. 52.

    Wang MY, Zhao FM, Peng HY, Lou CH, Li Y, Ding X, Yu XY, Yang GM, Xu DQ, Jiang LH, Zhang X, Ye LH, Cai BC. Investigation on the morphological protective effect of 5-hydroxymethylfurfural extracted from wine-processed Fructus corni on human L02 hepatocytes. J Ethnopharmacol. 2010;130:424–8.

    Article  PubMed  Google Scholar 

  53. 53.

    Jiang ZQ, Ma YX, Li MH, Zhan XQ, Zhang X, Wang MY. 5-Hydroxymethylfurfural protects against ER stress-induced apoptosis in GalN/TNF-α-injured L02 hepatocytes through regulating the PERK-eIF2α signaling pathway. Chin J Nat Med. 2015;13:896–905.

    PubMed  CAS  Google Scholar 

  54. 54.

    Park CH, Noh JS, Tanaka T, Roh SS, Lee JC, Yokozawa T. Polyphenol isolated from Corni Fructus, 7-O-galloyl-d-sedoheptulose, modulates advanced glycation endproduct-related pathway in type 2 diabetic db/db mice. Arch Pharmacal Res. 2015;38:1270–80.

    Article  CAS  Google Scholar 

  55. 55.

    Lee NH, Seo CS, Lee HY, Jung DY, Lee JK, Lee JA, Song KY, Shin HK, Lee MY, Seo YB, Kim H, Ha H. Hepatoprotective and antioxidative activities of Cornus officinalis against acetaminophen-induced hepatotoxicity in mice. Evid Based Complement Altern Med. 2012;2012:1–8.

    Google Scholar 

  56. 56.

    Sun H, Li L, Zhang A, Zhang N, Lv H, Sun W, Wang X. Protective effects of sweroside on human MG-63 cells and rat osteoblasts. Fitoterapia. 2013;84:174–9.

    Article  PubMed  CAS  Google Scholar 

  57. 57.

    Kim JY, Kim YK, Choi MK, Oh J, Kwak HB, Kim JJ. Effect of Cornus Officinalis on receptor activator of nuclear factor-kappaB ligand (RANKL)-induced osteoclast differentiation. J Bone Metab. 2012;19:121.

    Article  PubMed  PubMed Central  Google Scholar 

  58. 58.

    An YA, Hwang JY, Lee JS, Kim YC. Cornus officinalis methanol extract upregulates melanogenesis in melan-a cells. Toxicol Res. 2015;31:165–72.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  59. 59.

    Liu X, Zeng YQ, Liang YZ, Zou C, Liu H, Qiu F, Liang CL, Jin XW, Su ZR, Dai Z. Medicinal herbs Fructus corni and Semen cuscutae suppress allograft rejection via distinct immune mechanisms. Oncotarget. 2016;7:35680.

    PubMed  PubMed Central  Google Scholar 

  60. 60.

    Cho K, Lee HJ, Lee SY, Woo H, Lee MN, Seok JH, et al. Oleanolic acid and ursolic acid derived from Cornus officinalis Sieb. et Zucc. suppress epidermal growth factor- and phorbol ester-induced MUC5AC mucin production and gene expression from human airway epithelial cells. Phytother Res. 2011;25:760–4.

    Article  PubMed  CAS  Google Scholar 

  61. 61.

    Kim SH, Kim BK, Lee YC. Effects of Corni fructus on ovalbumin-induced airway inflammation and airway hyper-responsiveness in a mouse model of allergic asthma. J Inflamm. 2012;9:9.

    Article  CAS  Google Scholar 

  62. 62.

    Kang DG, Choi DH, Lee JK, Lee YJ, Moon MK, Yang SN, Kwon TO, Kwon JW, Kim JS, Lee HS. Endothelial NO/cGMP-dependent vascular relaxation of cornuside isolated from the fruit of Cornus officinalis. Planta Med. 2007;73:1436–40.

    Article  PubMed  CAS  Google Scholar 

  63. 63.

    Song JH, Park K, Shim A, Kwon BE, Ahn JH, Choi YJ, Kim JK, Yeo SG, Yoon K, Ko HJ. Complete sequence analysis and antiviral screening of medicinal plants for human Coxsackievirus A16 isolated in Korea. Osong Public Health Res Perspect. 2015;6:52–8.

    Article  PubMed  PubMed Central  Google Scholar 

  64. 64.

    Wu HZ. The clinical effect of Jinkui Shenqi pill on type 2 diabetes. Pharmacol Clin Chin Mater Med. 2013;29:191–3 (in Chinese).

    Google Scholar 

  65. 65.

    Liu ZW. Curative effect valuation on Jingui Senqi pill in the treatment of diabetic nephropathy. Chin J Basic Med Tradit Chin Med. 2014;20(821–2):31.

    Google Scholar 

  66. 66.

    Li X, Li Y. Clinical study on Liuwei Dihuang pills combined with liraglutide and metformin in treatment of type 2 diabetes mellitus. Drugs Clin. 2016;31:1146–50 (in Chinese).

    Google Scholar 

  67. 67.

    He K, Zhu LH, Lu XW. Clinical observation of Liuwei Dihuang pills combined with metformin in the treatment of type 2 diabetes. Chin Tradit Pat Med. 2016;38:50–2.

    Google Scholar 

  68. 68.

    Menzies FM, Fleming A, Rubinsztein DC. Compromised autophagy and neurodegenerative diseases. Nat Rev Neurosci. 2015;16:345–57.

    Article  PubMed  CAS  Google Scholar 

  69. 69.

    Nah J, Yuan J, Jung YK. Autophagy in neurodegenerative diseases: from mechanism to therapeutic approach. Mol Cells. 2015;38:381–9.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  70. 70.

    Zhou ZY. Chinese internal medicine. Beijing: China Press of Traditional Chinese Medicine; 2003. p. 157, 176, 183, 308, 316, 327 (in Chinese).

  71. 71.

    Lin SK, Yan SH, Lai JN, Tsai TH. Patterns of Chinese medicine use in prescriptions for treating Alzheimer’s disease in Taiwan. Chin Med. 2016;11:12.

    Article  PubMed  PubMed Central  Google Scholar 

  72. 72.

    Yeung WF, Chung KF, Zhang NL, Zhang SP, Yung KP, Chen PX, Ho YY. Identification of Chinese medicine syndromes in persistent insomnia associated with major depressive disorder: a latent tree analysis. Chin Med. 2016;11:4.

    Article  PubMed  PubMed Central  Google Scholar 

  73. 73.

    Cai H, Cao G, Cai B. Rapid simultaneous identification and determination of the multiple compounds in crude Fructus Corni and its processed products by HPLC–MS/MS with multiple reaction monitoring mode. Pharm Biol. 2013;51:273–8.

    Article  PubMed  CAS  Google Scholar 

  74. 74.

    Zhang YE, Liu EH, Li HJ, Li P. Chemical constituents from the fruit of Cornus officinalis. Chin J Nat Med. 2009;7:365–7 (in Chinese).

    Article  CAS  Google Scholar 

  75. 75.

    Han SY, Pan Y, Ding G, Cai BC. Application of 1H-NMR and 13C-NMR spectra in the structure identification of iridoids from Cornus officinalis. Chin Arch Tradit Chin Med. 2004;22:56–9 (in Chinese).

    Google Scholar 

  76. 76.

    Park JY, Han AR, Kil YS, Kang U, Kim SH, Nam SJ, Seo EK. A new secoiridoid glycoside from the fruits of Cornus officinalis (Cornaceae). Nat Prod Res. 2016;30:1504–10.

    Article  PubMed  CAS  Google Scholar 

  77. 77.

    He J, Ye XS, Wang XX, Yang YN, Zhang PC, Ma BZ, Zhang WK, Xu JK. Four new iridoid glucosides containing the furan ring from the fruit of Cornus officinalis. Fitoterapia. 2017;120:136–41.

    Article  PubMed  CAS  Google Scholar 

  78. 78.

    Han SY, Pan Y, Yang GM, Cai BC. Research on components of Cornus officinalis extracted by supercritical carbon dioxide. Zhongguo Zhong Yao Za Zhi. 2003;28:1148–50, 83 (in Chinese).

  79. 79.

    Kim DK, Kwak JY. A furan derivative from Comus officinalis. Arch Pharm Res. 1998;21:787–9.

    Article  PubMed  CAS  Google Scholar 

  80. 80.

    Xie X, Wang R, Shi Y. Chemical constituents from the fruits of Cornus officinalis. Biochem Syst Ecol. 2012;45:120–3.

    Article  CAS  Google Scholar 

  81. 81.

    Yang L, Wang Z, Huang L. Isolation and structural characterization of a polysaccharide FCAP1 from the fruit of Cornus officinalis. Carbohydr Res. 2010;345:1909–13.

    Article  PubMed  CAS  Google Scholar 

  82. 82.

    Wang LL, Zhang T, Chen SQ, Shang CL. Study on the correlation between the quality of Cornus officinalis and the contents of the inorganic elements in the planting soil. Zhong Yao Cai. 2011;34:1167–72 (in Chinese).

    PubMed  CAS  Google Scholar 

  83. 83.

    Hsu JH, Wu YC, Liu IM, Cheng JT. Release of acetylcholine to raise insulin secretion in Wistar rats by oleanolic acid, one of the active principles contained in Cornus officinalis. Neurosci Lett. 2006;404:112–6.

    Article  PubMed  CAS  Google Scholar 

  84. 84.

    Gu H, Jiang Z, Wang M, Jiang H, Zhao F, Ding X, Cai B, Zhan Z. 5-Hydroxymethylfurfural from wine-processed Fructus corni inhibits hippocampal neuron apoptosis. Neural Regen Res. 2013;8:2605–14.

    PubMed  PubMed Central  CAS  Google Scholar 

  85. 85.

    Zhang QC, Zhao Y, Bian HM. Antiplatelet activity of a novel formula composed of malic acid, succinic acid and citric acid from Cornus officinalis fruit. Phytother Res. 2013;27:1894–6.

    Article  PubMed  CAS  Google Scholar 

Download references

Authors’ contributions

YD conducted literature searches, extracted and analyzed data and drafted the manuscript and prepared tables and figures. ZLF contributed to the proofreading of chemical constituents and structures. FSW contributed to the draft of the fundamental theories of traditional Chinese medicine of the review. HBC contributed to the revisions of the manuscript. JHL designed the study, developed and revised the manuscript and is the corresponding author. All authors read and approved the final manuscript.


Not applicable.

Competing interests

The authors declare that they have no competing interests.

Availability of data and materials

All data used in this systematic review are fully available in the public domain.

Consent for publication

Not applicable.

Ethics approval and consent to participate

Not applicable.


This work was supported by Macau government Grants FDCT-022/2015/A1 and FDCT-092-2015-A3, the University of Macau Grants MYRG2016-0019-ICMS -QRCM and MYRG2017-00147-ICMS awarded to Jia-Hong Lu.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Author information



Corresponding author

Correspondence to Jia-Hong Lu.

Rights and permissions

Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (, which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver ( applies to the data made available in this article, unless otherwise stated.

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Dong, Y., Feng, Z., Chen, H. et al. Corni Fructus: a review of chemical constituents and pharmacological activities. Chin Med 13, 34 (2018).

Download citation


  • Cornus officinalis Sieb. et Zucc.
  • Corni Fructus
  • Shan Zhu Yu
  • Phytochemistry
  • Pharmacological activity